Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis.
Journal: Focus (American Psychiatric Publishing)
Published: August 01, 2026
Assessing Drug Efficacy After Multiple Negative Trials-Gepirone's Journey Through the FDA.
Journal: JAMA psychiatry
Published: June 24, 2026
Ending publication bias: A values-based approach to surface null and negative results.
Journal: PLoS biology
Published: September 24, 2025
Characteristics of Trials Preceding FDA Approval of Novel Psychiatric Drugs.
Journal: JAMA network open
Published: January 27, 2025
Fragile promise of psychedelics in psychiatry.
Journal: BMJ (Clinical research ed.)
Published: November 19, 2024
ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis.
Journal: BMJ (Clinical research ed.)
Published: November 20, 2023
Unpublished trials of alprazolam XR and their influence on its apparent efficacy for panic disorder.
Unpublished trials of alprazolam XR and their influence on its apparent efficacy for panic disorder.
Journal: Psychological medicine
Published: October 19, 2023
Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder.
Journal: The Cochrane database of systematic reviews
Published: September 12, 2021
An open science pathway for drug marketing authorization-Registered drug approval.
Journal: PLoS medicine
Published: August 09, 2021
Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials.
Journal: PLoS medicine
Published: August 04, 2021
Last Updated: 09/26/2026